Abstract:signaling pathways remains largely unclear. ARID1A and ARID1B are two mutually exclusive subunits serving as the rigid structural core in the BAF complex, a SWI/SNF family chromatin remodeler that regulates chromatin packing and transcription by controlling the dynamics of nucleosomes. Mutational landscape analyses have revealed that ARID1A is among the most frequently mutated epigenetic factors across many cancer types, with ∼12% ARID1A mutation in CRC ( Luo et al., 2020 ) . Many synthetic lethality targets of ARID1A have been identified, including ARID1B, EZH2, HDAC6, Aurora A, and GCLC. Particularly, ARID1A-mutated cancer cells manifest enhanced BRD4 activity, rendering the cells hypersensitive to bromodomain and extra-terminal domain inhibitors ( Nagarajan et al., 2020 ) . BRD4 is a binding partner of the Mediator complex and well known for its role in the organization and function of superenhancers, which are large clusters of enhancers with exceptionally high densities of transcription factor ( TF ) binding. Both BRD4 and components in the Mediator complex can undergo liquid– liquid phase separation, forming transcriptional coactivator condensates to bridge TFs with RNA polymerase II ( Sabari et al., 2018 ) . How ARID1A-mutated cancer cells harness this transcriptional coactivator module was an enigma. Yu et al. ( 2022 ) recently reported that mutation of ARID1A in CRC results in an abnormal activation of a group of HERVH loci, which involves ARID1B-dependent chromatin remodeling activity and the TF SP1. The HERVH transcripts partition into nuclear BRD4 condensates and likely co-opt its coactivator activity to drive downstream oncogenic gene network ( Figure 1 ) . Downregulation of HERVH transcript level effectively inhibits the proliferation of colorectal cells as well as patient-derived CRC organoids, suggesting the existence of molecular addictions of these cells to the activated HERVH elements. This study has revealed an unexpected function of ARID1A–BAF chromatin remodeler in restraining the activity of HERVH. More importantly, it suggests that HERVH transcripts steer the BRD4 coactivator module to promote oncogenicity. Whether HERVH RNAs directly bind to BRD4 and the Mediator complex to alter their target selection requires future biochemical interrogations. Of note, a recent study in mouse ESCs reports that RNAs of murine ERVs, such as intracisternal A-type particles, facilitate partitioning of the Mediator coactivator as well as RNA polymerase II into phaseseparated droplets, thereby hijacking the transcriptional condensates away from pluripotency ( Asimi et al., 2022 ) . It is compelling to speculate that the RNA species originated from ERVs are able to rewire the transcriptional circuitries via the coactivator module in evolution. Cancer development in many aspects parallels the process of early embryogenesis. The work from Yu et al. ( 2022 ) uncovers that mutation of a tumor suppressor ARID1A reactivates a group of pluripotency-related HERVH, With sequence similarities to exogenous retroviruses, the proviral DNA elements named endogenous retroviruses ( ERVs ) make up ∼8% of human genome, threatening genomic stability meanwhile nurturing regulatory innovations. Diverse host epigenetic mechanisms are enlisted to limit the ERVs’ activity. However, in certain physiological and pathophysiological processes, distinct ERVs become abnormally activated, rewiring and perplexing the host regulons at different levels ( Cosby et al., 2019 ) . ERVs not only contribute to the nuclear architecture; once activated, they can also act as enhancers, promoters, or even be exonized to shape the transcriptional circuitries. Moreover, some ERVs are able to synthesize regulatory noncoding RNA species or functional polypeptides to impact the transcriptome as well as the proteome. As one of the most abundant ERV groups, the transcriptional activation of human endogenous retrovirus H ( HERVH ) is crucial for the acquisition and maintenance of the pluripotent state of human embryonic stem cells ( ESCs ) as well as the induced pluripotent stem cells ( Rodriguez-Terrones and TorresPadilla, 2018 ) . HERVH is also active in several types of cancer including colorectal cancer ( CRC ) , yet how it is activated and influences carcinogenic

Stem cell activity-coupled suppression of endogenous retrovirus governs adult tissue regeneration

Abstract 1244: Exploiting the pathogenesis of endogenous retrovirus to tackle squamous cancers

Nuclear RNA catabolism controls endogenous retroviruses, gene expression asymmetry, and dedifferentiation

Hijacking of transcriptional condensates by endogenous retroviruses

Kru euro ppel-like factor 5 rewires NANOG regulatory network to activate human naive pluripotency specific LTR7Ys and promote naive pluripotency

Noncoding dsRNA induces retinoic acid synthesis to stimulate hair follicle regeneration via TLR3

Resurrection of endogenous retroviruses during aging reinforces senescence

Signalling by senescent melanocytes hyperactivates hair growth

Transcriptionally Active HERV-H Retrotransposons Demarcate Topologically Associating Domains in Human Pluripotent Stem Cells

Endogenous retroviral ERVH48-1 promotes human urine cell reprogramming

Endogenous Retroviruses in Development and Health.

Rewiring the Transcriptional Circuitries in Cancer by Endogenous Retroviruses

Setdb1 protects genome integrity in murine muscle stem cells to allow for regenerative myogenesis and inflammation

Hoxc-Dependent Mesenchymal Niche Heterogeneity Drives Regional Hair Follicle Regeneration.

TNRC18 engages H3K9me3 to mediate silencing of endogenous retrotransposons

Rif1 Promotes a Repressive Chromatin State to Safeguard Against Endogenous Retrovirus Activation.

Dynamic Transcription of Distinct Classes of Endogenous Retroviral Elements Marks Specific Populations of Early Human Embryonic Cells.

Activation of endogenous retroviruses during brain development causes an inflammatory response

Glucocorticoid signaling and regulatory T cells cooperate to maintain the hair-follicle stem-cell niche

Enigma of Retrotransposon Biology in Mammalian Early Embryos and Embryonic Stem Cells

The Retrovirus HERVH is a Long Noncoding RNA Required for Human Embryonic Stem Cell Identity